Garg Pushkal 4
4 · ALNYLAM PHARMACEUTICALS, INC. · Filed Mar 6, 2026
Research Summary
AI-generated summary of this filing
Alnylam (ALNY) EVP Garg Pushkal Sells 4,713 Shares (~$1.525M)
What Happened
Garg Pushkal, Executive Vice President & Chief R&D Officer at Alnylam Pharmaceuticals, sold a total of 4,713 shares of ALNY common stock in open-market transactions on March 4–5, 2026. Sales were executed at prices ranging approximately from $319.03 to $326.08, generating aggregate proceeds of about $1,524,795. Several sales were automatic “sell‑to‑cover” transactions to satisfy tax withholding on vested RSUs; some sales were executed pursuant to a previously adopted Rule 10b5‑1 trading plan.
Key Details
- Transaction dates: March 4 and March 5, 2026. Prices reported ranged roughly $319.03–$326.08 (some entries are weighted averages across multiple trades).
- Total shares sold: 4,713. Total proceeds: ≈ $1.525 million.
- Shares owned after the transaction: Not specified in the provided filing data.
- Notable footnotes: F1 indicates mandatory sell‑to‑cover for tax withholding; F10 notes a Rule 10b5‑1 plan; several F11–F14 footnotes indicate weighted‑average prices across multiple sales.
- Transaction code: S = Sale.
- Timeliness: Filing dated March 6, 2026 for trades on March 4–5, 2026 — appears to be filed within the usual two‑business‑day Form 4 window.
Context
These transactions include routine sell‑to‑cover activity tied to RSU vesting and planned sales under a 10b5‑1 program. Such sales are generally considered routine and do not, by themselves, indicate management’s view on the company’s near‑term prospects. As always, investors should consider insider activity alongside other company and market information.
Insider Transaction Report
Form 4
Garg Pushkal
EVP Chief R&D
Transactions
- Sale
Common Stock
[F1][F2]2026-03-04$319.03/sh−106$33,817→ 23,300 total - Sale
Common Stock
[F1][F3]2026-03-04$320.01/sh−102$32,641→ 23,198 total - Sale
Common Stock
[F1][F4]2026-03-04$320.81/sh−215$68,974→ 22,983 total - Sale
Common Stock
[F1][F5]2026-03-04$321.82/sh−289$93,006→ 22,694 total - Sale
Common Stock
[F1][F6]2026-03-04$323.01/sh−350$113,054→ 22,344 total - Sale
Common Stock
[F1][F7]2026-03-04$323.84/sh−767$248,385→ 21,577 total - Sale
Common Stock
[F1][F8]2026-03-04$324.88/sh−272$88,367→ 21,305 total - Sale
Common Stock
[F1][F9]2026-03-04$325.67/sh−208$67,739→ 21,097 total - Sale
Common Stock
[F10][F11]2026-03-05$322.33/sh−654$210,804→ 20,443 total - Sale
Common Stock
[F10][F12]2026-03-05$323.55/sh−740$239,427→ 19,703 total - Sale
Common Stock
[F10][F13]2026-03-05$324.59/sh−510$165,541→ 19,193 total - Sale
Common Stock
[F10][F14]2026-03-05$326.08/sh−500$163,040→ 18,693 total
Holdings
- 431(indirect: by Managed Account)
Common Stock
[F15] - 250(indirect: By Trust)
Common Stock
[F16]
Footnotes (16)
- [F1]Represents shares automatically sold by the Company on behalf of the reporting person pursuant to a mandatory sell-to-cover provision in the award agreement to cover minimum statutory tax withholding obligations upon the vesting of restricted stock units.
- [F10]This transaction was made pursuant to a Rule 10b5-1(c) trading plan adopted by the Reporting Person on November 20, 2025.
- [F11]The price reported represents the weighted average sales price of shares sold in multiple transactions at prices ranging from $322.03 to $322.96. The reporting person will provide to the issuer, any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range.
- [F12]The price reported represents the weighted average sales price of shares sold in multiple transactions at prices ranging from $323.09 to $324.08. The reporting person will provide to the issuer, any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range.
- [F13]The price reported represents the weighted average sales price of shares sold in multiple transactions at prices ranging from $324.26 to $325.20. The reporting person will provide to the issuer, any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range.
- [F14]The price reported represents the weighted average sales price of shares sold in multiple transactions at prices ranging from $325.67 to $326.40. The reporting person will provide to the issuer, any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range.
- [F15]Reflects shares of ALNY common stock acquired by the Reporting Person under the issuer 401(k) plan as a result of the issuer 401(k) matching contribution program.
- [F16]Represents shares held in trust, of which the Reporting Persons spouse is co-trustee. The Reporting Person disclaims beneficial ownership of these shares, and the filing of this report is not an admission that the Reporting Person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose.
- [F2]The price reported represents the weighted average sales price of shares sold in multiple transactions at prices ranging from $318.27 to $319.27. The reporting person will provide to the issuer, any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range.
- [F3]The price reported represents the weighted average sales price of shares sold in multiple transactions at prices ranging from $319.28 to $320.28. The reporting person will provide to the issuer, any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range.
- [F4]The price reported represents the weighted average sales price of shares sold in multiple transactions at prices ranging from $320.33 to $321.33. The reporting person will provide to the issuer, any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range.
- [F5]The price reported represents the weighted average sales price of shares sold in multiple transactions at prices ranging from $321.34 to $322.31. The reporting person will provide to the issuer, any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range.
- [F6]The price reported represents the weighted average sales price of shares sold in multiple transactions at prices ranging from $322.36 to $323.36. The reporting person will provide to the issuer, any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range.
- [F7]The price reported represents the weighted average sales price of shares sold in multiple transactions at prices ranging from $323.38 to $324.35. The reporting person will provide to the issuer, any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range.
- [F8]The price reported represents the weighted average sales price of shares sold in multiple transactions at prices ranging from $324.39 to $325.38. The reporting person will provide to the issuer, any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range.
- [F9]The price reported represents the weighted average sales price of shares sold in multiple transactions at prices ranging from $325.40 to $326.21. The reporting person will provide to the issuer, any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range.
Signature
By: Brett Budzinski, Attorney-in-Fact For: Pushkal Garg|2026-03-06